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High intraocular pressure (IOP) is an important risk 
factor for both the development and progression of glaucoma. 
In experimental animal models [1] as well as in humans [2] 
exposure to elevated IOP correlates with retinal ganglion 
cell (RGC) loss and optic nerve (ON) degeneration. In fact, 
lowering IOP is currently the only therapeutic means of 
slowing or halting the disease process.
Complement upregulation has been reported as an early 
event in the development of glaucoma. Studies in human 
glaucomatous tissue [3,4] and experimental animal models 
[5-7] have shown that complement system components are 
upregulated in the retina in both early and late stages of the 
disease.
The complement system is part of the innate immune 
system. Its functions are to opsonize antigens, recruit 
macrophages, and cause the lysis of bacterial pathogens 
by forming the terminal complement complex (TCC) [8,9]. 
The complement system comprises several dozen proteins 
that are synthesized mainly in the liver and circulate in the 
blood stream; some of the complement components can also 
be found on cell membranes. The circulating complement 
proteins do not cross the blood–brain and the blood–retina 
barriers because of their large size. To provide local protec-
tion, they are synthesized locally within the central nervous 
system (CNS). Several of the complement proteins, including 
complement component 1, q subcomponent (C1q) and comple-
ment component 3 (C3), have been shown to be expressed in 
the retina under normal conditions, albeit at low levels [4,10].
Locally produced complement components in the CNS 
may have additional roles besides their direct immunological 
functions. Recent studies have suggested that complement 
may participate in normal developmental processes, such 
as pruning of synapses [11] and other developmental and 
degenerative processes [9,12], implicating it in diseases such 
as schizophrenia [13,14], Alzheimer disease [15], Parkinson 
disease [16], and glaucoma [17].
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Purpose: To determine whether short-term pressure elevation affects complement gene expression in the retina in vitro 
and in vivo.
Methods: Muller cell (TR-MUL5) cultures and organotypic retinal cultures from adult mice and monkeys were sub-
jected to either 24-h or 72-h of pressure at 0, 15, 30, and 45 mmHg above ambient. C57BL/6 mice were subjected to 
microbead-induced intraocular pressure (IOP) elevation for 7 days. RNA and protein were extracted and used for analysis 
of expression levels of complement component genes and complement component 1, q subcomponent (C1q) and comple-
ment factor H (CFH) immunoblotting.
Results: mRNA levels of complement genes and C1q protein levels in Muller cell cultures remained the same for all 
pressure levels after exposure for either 24 or 72 h. In primate and murine organotypic cultures, pressure elevation 
did not produce changes in complement gene expression or C1q and CFH protein levels at either the 24-h or 72-h time 
points. Pressure-related glial fibrillary acidic protein (GFAP) mRNA expression changes were detected in primate retinal 
organotypic cultures (analysis of variance [ANOVA]; p<0.05). mRNA expression of several other genes changed as a 
result of time in culture. Eyes subjected to microbead-induced IOP elevation had no differences in mRNA expression of 
complement genes and C1q protein levels (ANOVA; p>0.05 for both) with contralateral control and naïve control eyes.
Conclusions: Short-term elevation of pressure in vitro as well as short-term (1 week) IOP elevation in vivo does not 
seem to dramatically alter complement system gene expression in the retina. Prolonged expression to elevated pressure 
may be necessary to affect the complement system expression.
Correspondence to: Konstantin Astafurov, Department of Cell 
Biology, Box 5, SUNY Downstate Medical Center, 450 Clarkson 
Ave, Brooklyn, NY 11203; Phone: (718) 270-8049; FAX: (718) 270-
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Given the central role of IOP elevation in glaucomatous 
pathophysiology and the role of the complement system in the 
same process, we examined whether short-term increases in 
pressure affect complement expression in an immortalized 
Muller cell line and organotypic retinal cultures in vitro. We 
also examined whether complement is affected by relatively 
short (1 week) IOP elevation in vivo in a microbead-induced 
model of ocular hypertension in mice.
METHODS
Cell cultures: Conditionally immortalized cell line of Muller 
cells (TR-MUL5; originally described in [18]) were used and 
maintained in culture as previously described [19]. The cell 
line was kindly provided by Dr. Thomas Weber (Mount Sinai 
School of Medicine, New York, NY).
TR-MUL5 cells were kept at 34 °C in high glucose 
Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Invi-
trogen, Carlsbad, CA), 10% heat-inactivated fetal bovine 
serum (FBS; Gibco, Invitrogen), penicillin and streptomycin 
(Gibco, Invitrogen) in noncoated culture f lasks. Cells at 
approximately 30% confluence were used for pressurization. 
Immediately before pressurization the cells were transferred 
to serum-free media and kept there for the duration of the 
experiment.
Animals: All procedures were performed in accordance with 
the Association for Research in Vision and Ophthalmology 
Statement for the Use of Animals in Ophthalmic and Vision 
Research. All animal protocols in the current study and 
previous studies described were approved by the Institutional 
Animal Care and Use Committee (IACUC) committee of 
SUNY Downstate Medical Center (New York, NY).
A group of 3- to 5-month-old C57BL/6 mice from the 
colony that we maintain (SUNY Downstate Medical Center) 
was used in the experiments. Mice were kept in a 12 h:12 h 
light–dark cycle and fed ad libitum.
Retinas from four normally reared young adult (6–9-
years old) female bonnet macaque (Macaca radiata) monkeys 
were obtained immediately after sacrifice. These monkeys 
were part of the control (untreated) group of an unrelated 
experiment (to study whether antidepressants affect neuro-
genesis), which was approved by a separate IACUC protocol. 
All monkeys were housed in accordance with the guidelines 
of the IACUC in a social pen containing eight subjects. For 
the duration of 10 weeks before sacrifice, the animals were 
sedated with ketamine once a week to receive a placebo via 
a gastric tube. No other experimental manipulations were 
performed. All monkeys received food and water ad libitum 
for the duration of the study. Prior to sacrifice, monkeys were 
anesthetized to a surgical depth with sodium pentobarbital 
(12.5 mg/kg intravenously [IV]) with the goal of maintaining 
a deep sedation and minimizing discomfort. The depth of 
anesthesia was confirmed as indicated by the absence of pain 
reflexes, which was assessed by compressing the tail and 
orbital fissure, and the absence of deep tendon reflexes of the 
knee. The heart was exposed and a cannula inserted through 
an incision in the left ventricle into the ascending aorta and 
secured with a Babcock clamp. The descending aorta was 
clamped with a hemostat and the right atrium incised. Using 
a peristaltic pump, cold saline was infused for 10 min to clear 
blood vessels.
Retinal organotypic cultures: Mouse retinal organotypic 
cultures were prepared from 3−5-month-old (n=40) C57BL/6 
mice as previously described [20]. Briefly, animals were anes-
thetized using ketamine (400 mg/kg) and xylazine (80 mg/
kg), and after cervical dislocation the eyes were immediately 
enucleated. The retinas were removed under sterile conditions 
in ice-cold Hank’s balanced salt solution (HBSS; Fisher, Pitts-
burgh PA). Relaxing incisions were made to create flatmounts 
that were placed in cell culture inserts (see below).
Primate organotypic cultures were similarly prepared 
after sacrifice following transcardial perfusion with ice-cold 
saline solution for 10 min. Immediately following the perfu-
sion, eyes were enucleated and quickly dissected under sterile 
conditions in ice-cold HBSS. Four punches were made in 
each retina with a disposable skin biopsy punch (3 mm), one 
from each quadrant at the center of the quadrant between the 
optic nerve head and the edge of the retina.
Explants were mounted on cell culture inserts (BD 
Biosciences, San Jose, CA) with an 8-μm pore size and 
cultured overnight in N-2 (Gibco, Invitrogen), B-27 (Gibco, 
Invitrogen), and L-glutamine (Gibco, Invitrogen)-supple-
mented neurobasal medium (Gibco, Invitrogen), at 34 °C in 
24-well plates (BD Biosciences). The following day, fresh 
medium was added to the cultures immediately before pres-
surization. After pressurization, the retinal cultures were 
immersed in Trizol reagent (Invitrogen, Carlsbad, CA) for 
RNA and protein extraction.
Pressure elevation: The cells and organotypic retinal cultures 
were subjected to different levels of pressure in a set of four 
polycarbonate pressure chambers that were kept in an incu-
bator at 34 °C for either 24 or 72 h. Pressure was adjusted 
to 15 (±3) mmHg, 30 (±3) mmHg, and 45 (±3) mmHg above 
ambient in three of the chambers, while the fourth chamber 
was maintained at ambient pressure. Pressure was regulated 
with a custom-made active feedback electronic system that 
injected a mixture of 95% air/5% CO2 until the desired pres-
sure was reached and maintained it with short bursts of gas. 
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Pressure and temperature was continuously monitored and 
recorded in each chamber for the duration of the experiment 
by an in-house built data logger; data were downloaded to 
a personal computer for evaluation. All pressure exposure 
experiments were performed at least in triplicate for cells and 
quadruplicate for organotypic retinal cultures at each pres-
sure level. Figure 1 shows a typical graph of pressure and 
temperature during a 72-h experiment.
Intraocular pressure elevation in vivo: IOP elevation was 
induced in one eye of sixteen 3-month-old male C57BL/6 
mice by injection of 10-µm-diameter polystyrene beads 
(Invitrogen) as described previously [21]. Briefly, the animals 
were anesthetized as above, a small incision was made with 
a number 30G needle, and a pulled glass micropipette was 
used to inject 1–2 μl of the polystyrene beads into the anterior 
chamber (AC) of one eye. The contralateral eye remained 
uninjected and served as control. The animals were allowed 
to survive for 7 days, after which they were anesthetized as 
above, perfused intracardially with PBS (0.1 M, 137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 
7.4), and the retinas were dissected out. In all animals base-
line IOP was measured before treatment. After treatment, IOP 
was repeatedly measured and recorded every 2 days (totaling 
three times during the 7-day interval) using a prototype 
rebound tonometer as previously described [22]. Briefly, IOP 
was measured in awake, nonsedated mice that were restrained 
in a custom made restrainer that allows measurement of IOP 
without causing an increase in intrathoracic pressure. After 
mice were put in the restrainer, tetracaine 0.5% was applied 
to each eye prior to IOP measurements. Five measurements 
were taken from each eye and averaged; IOP was calcu-
lated using the tonometer calibration formula as previously 
described [22]. Only animals that demonstrated elevated IOP 
after the intraocular bead injection (n=10) were used in the 
experiments. Nine eyes from a separate group of untreated 
3-month-old male mice (n=7) served as a naïve control group.
Cumulative IOP exposure was calculated as a sum of the 
products of a measured IOP value on a particular day and the 
number of days since the last IOP measurement. Peak IOP 
was defined as the highest IOP value of all measurements 
from one eye. Average IOP was calculated as the average of 
the three IOP values during the 7-day interval.
Real-time quantitative PCR: RNA was extracted from cells, 
retinal explants, and mouse retinas from sacrificed mice 
using Trizol reagent (Invitrogen) according to the manufac-
turer’s instructions. Cells, retinal explants, and mouse retinas 
from sacrificed mice were homogenized using a drive motor 
homogenizer Tissumizer SDT 181 (Tekmar, Cincinnati, OH) 
and total RNA was isolated using Trizol reagent (Invitrogen) 
according to the manufacturer’s instructions. The RNA 
was precipitated with isopropanol, washed in 70% ethanol, 
and column purified (RNAeasy mini kit; Qiagen, Valencia, 
CA). RNA quality was assessed by the 260/280 ratio using 
a Nanodrop ND-1000 spectrophotometer (Nanodrop Tech-
nologies; Wilmington, DE). It was then reverse transcribed 
to cDNA with a random primer as per the manufacturer’s 
instructions (Quantitect; Qiagen). 1000 ng of isolated total 
RNA was then reverse transcribed to cDNA using random 
hexamer primers following the manufacturer’s instructions 
(Quantitect; Qiagen). cDNA was processed for real-time 
quantitative PCR (RT-qPCR) with Power SYBR Green 
master mix (Applied Biosystems, Carlsbad, CA or Biobasic, 
Canada) and gene-specific primers. RT-qPCR was performed 
for the following mouse genes (gene name followed by 
GenBank accession number in parenthesis): complement 
component 1, sub component q (C1qbp; NM_007573.2), 
complement component 2 (C2; NM_013484.2), comple-
ment component 4B (C4b; NM_009780.2), complement 
factor H (CFH; NM_009888.3), thymus cell antigen 1, 
theta (Thy1; NM_009382.3), synuclein gamma (Sncg; 
NM_011430.2), and GFAP (NM_010277.3); RT-PCR was 
also performed for the following primate genes (gene name 
followed by GenBank accession number in parenthesis): 
C1qb (XM_001083650.2), CFH (XM_001111875.2), CD46 
antigen, complement regulatory protein (CD46; AB172248.1), 
complement factor properdin (CFP; JU473400.1), comple-
ment regulator complement receptor 1-related gene/protein-
y (CRRY; XM_002801945.1), decay accelerating factor for 
complement (DAF; XM_001112168.2), complement factor I 
(CFI; XM_001087512), serpin peptidase inhibitor, clade G 
(C1 inhibitor), member 1 (SERPING1; NC_007871.1), Thy1 
(NM_001042638), and GFAP (XM_001102095) genes. All 
samples were run in triplicate and were analyzed on the 
Applied Biosystems 7900HT Fast Real-Time PCR System. 
Statistical analysis was performed using the delta-delta 
threshold cycle (Ct) method [23] after normalization using 
the mouse ribosomal protein S11 (RPS11) gene (GenBank 
Figure 1. Typical pressure and temperature graph of a 72-h pres-
surization experiment. The four chambers were maintained at 0, 15, 
33, and 46 mmHg while temperature was 34.5 °C.
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accession number NM_013725.4) and primate RPS11 gene 
(GenBank accession number NM_001195754.1). Outliers 
were removed using Grubbs’ test [24].
Protein immunoblotting: Proteins were extracted from the 
organic phase of Trizol by dialyzing against three changes of 
0.1% sodium dodecyl sulfate (SDS) at 4 °C for 48 h as previ-
ously described [25]. Protease inhibitors were added, and the 
samples were stored at −80 °C until used. Similarly, protein 
in the cell culture media was dialyzed as above and stored at 
−80 °C. Protein samples were concentrated using Amicon 
centrifugal filters (Millipore, Billerica, MA), diluted in 
Laemmli sample buffer (BioRad, Hercules, CA), separated in 
a 4%–20% SDS– polyacrylamide gel electrophoresis (PAGE) 
gel (Bio-Rad, Hercules, CA), and transferred to polyvinyli-
dene fluoride (PVDF) membranes. The membranes were then 
blocked (Superblock; Thermo Fisher Scientific, Rockford, IL) 
and incubated with either a mouse monoclonal anti-C1q anti-
body (Abcam, Cambridge, MA; 1:2,000, overnight at 4 °C) 
or a goat polyclonal anti-CFH antibody (1:3,000, overnight 
at 4 °C; Quidel, catalog# A312; San Diego, CA), followed 
by incubation with a horseradish peroxidase-conjugated 
secondary antibody (Jackson Immunoresearch, West Grove, 
PA) for 2 h at room temperature. A rabbit anti-β-actin-specific 
antibody (1:5,000, overnight at 4 °C; Abcam) was used to 
detect β-actin, which served as a loading control.
Antibody binding was visualized with a chemilumines-
cence kit (ECL; Pierce, Rockford, IL) on an image station 
(Kodak 440CF; Kodak, Boston, MA) and quantified with 
ImageJ image-analysis software (developed by Wayne 
Rasband, National Institutes of Health, Bethesda, MD). For 
C1q, the sum of the normalized integrated density of all the 
bands was used for quantification.
Statistical analysis: The difference between Ct values of each 
gene under investigation and RPS11 (40S ribosomal protein 
S11) housekeeping gene was calculated (dCt) and normalized 
by subtraction of the Ct values of the samples in the 0 mmHg 
group (ddCt). Results were subjected to two-way analysis of 
variance (ANOVA) for treatment (pressure level) and length 
of incubation (24 or 72 h) for cultures using NCSS (Kaysville, 
UT). Fold changes were calculated (as 2–ddCt) for each replicate 
and then averaged among samples in each treatment group for 
graphing. For IOP experiments, t test or one-way ANOVA 
was used where appropriate. Significant differences (p<0.05) 
were further explored with Tukey–Kramer post hoc analysis.
Protein levels were normalized to the levels of β-actin 
and were subjected to statistical analysis using ANOVA. 
Tables were prepared using Microsoft Excel (Microsoft, 
Seattle, WA).
RESULTS
Effect of elevated pressure on isolated retinal cell cultures: 
Expression levels of C1q, C2, C4, CFH, and CFI mRNA were 
not significantly different (ANOVA; p>0.05) in TR-MUL5 
cells in cultures subjected to elevated pressure for either 24 
or 72 h (data not shown). Levels of C3 mRNA were low and 
could not be reliably assessed in the samples analyzed.
Immunoblotting for C1q also did not detect any 
significant differences in the protein levels after 24 and 72 
hours exposure to elevated pressure (ANOVA; p>0.05) in 
TR-MUL5 cell cultures (Figure 2).
Effect of elevated pressure on organotypic retinal cultures: 
No significant changes were detected in gross morphology 
or retinal cytoarchitecture after culturing either murine or 
primate retinal explants for 3 days. The effects of pressure 
on mRNA expression of various complement components in 
mouse and primate retinal organotypic cultures are presented 
in Figure 3 and Figure 4, respectively.
Figure 2. Extracellular complement 
component 1, q subcomponent 
(C1q) protein levels in Muller cell 
line TR-MUL5 cultures subjected 
to different pressure levels. Shown 
are representative immunoblots 
of extracellular C1q levels in 
TR-MUL5 cell cultures subjected 
to various levels of pressure (0, 15, 
30, and 45 mmHg above ambient) 
for either (A) 24 or (B) 72 h. 
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Levels of mRNA of complement genes did not differ 
across groups with different pressure exposure for either 24 
h or 72 h of pressurization (two-way ANOVA comparison 
by pressure exposure; p>0.05) for both mouse and primate 
retinal explants. In addition, none of the other proteins 
studied showed any pressure effect in mouse cultures. Pres-
sure caused a significant effect on GFAP mRNA expression 
(ANOVA; p=0.027) in primate retinal organotypic cultures 
after 24 h.
mRNA levels of Thy 1, GFAP, C2, and C4b were 
significantly affected by time in culture (but not by pres-
sure exposure; two-way ANOVA; p<0.0002, 0.0057, 0.012, 
and 0.00006, respectively) in organotypic retinal cultures 
from C57BL/6 mice. At the same time, for primate retinas 
mRNA levels of Thy1, GFAP, SerpinG1, and CFI were also 
significantly affected by time in culture (but not by pressure 
exposure; two-way ANOVA; p<0.00001, p<0.005, p<0.00001, 
and p=0.028, respectively).
Protein levels of C1q (as determined by immunoblot-
ting) remained unchanged (ANOVA; p>0.05) by exposure to 
various pressure levels after 24 and 72 h in both mouse (data 
not shown) and monkey (Figure 5A,B) organotypic retinal 
cultures. CFH immunoreactive protein also did not show any 
significant differences (ANOVA; p>0.05) between primate 
retinal organotypic cultures subjected to different pressure 
levels for 72 h (Figure 5C).
Effect of elevated intraocular pressure elevation in vivo: 
Of the 16 mice injected with microbeads, ten demonstrated 
increased IOP during the time of the experiment. Only those 
mice were included in the final analysis. Mean (±standard 
error of the mean [SEM]) cumulative IOP exposure was 
137.66±8.18 mmHg ×days for the eyes injected with micro-
beads, 106.84±5.42 mmHg*days for contralateral eyes of the 
same animals, and 108.39±3.88 mmHg*days for the eyes of 
the naïve mice.
Peak (mean±SEM) IOP was 25.12±2.54 mmHg for eyes 
injected with microbeads, 18.38±1.19 mmHg for contralateral 
eyes, and 15.48±0.55 mmHg for naïve eyes.
Average (mean±SEM) IOP of all mice was 
18.72±1.56 mmHg for eyes injected with micro-
beads, 14.13±0.61 mmHg for contralateral eyes, and 
15.48±0.55 mmHg for naïve eyes.
Cumulative IOP exposure for the eyes injected with 
microbeads was statistically significantly higher (ANOVA; 
p<0.007) compared to nontreated contralateral eyes and 
eyes from naïve animals (Tukey–Kramer post hoc analysis; 
p<0.05; Figure 6). Microbead-injected eyes also had 
Figure 3. Real-time reverse tran-
scription polymerase chain reaction 
(RT–PCR) analysis of mouse retinal 
organotypic cultures subjected to 
different pressure levels. RT–PCR 
assays were performed to detect 
changes in mRNA expression 
levels in mouse retinal organotypic 
cultures subjected to different 
levels of pressure for 24 h (A) 
and 72 h (B). Fold changes are 
expressed in comparison to the 
average mRNA levels in cultures 
exposed to ambient atmospheric 
pressure (0 mmHg; thus the 0 
mmHg group would have a mean 
of 1). Error bars represent standard 
error of the mean.
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statistically significantly higher peak IOP (ANOVA; p<0.013) 
and average IOP (ANOVA; p<0.025) values compared to the 
nontreated contralateral and naïve eyes.
mRNA expression levels of the genes studied were 
found to be similar in the retinas from the eyes subjected to 
increased IOP versus retinas from contralateral eyes (Figure 
7A) when normalized to the mRNA levels from the retinas of 
naïve animals (t test; p>0.05).
C1q immunoblotting did not reveal any differences in 
the levels of C1q protein (ANOVA; p>0.05) between retinas 
subjected to IOP elevation, contralateral control retinas of the 
same animals, or retinas of naïve mice (Figure 7B).
Figure 4. Real-t ime reverse 
transcription polymerase chain 
react ion (RT–PCR) analysis 
of primate retinal organotypic 
cultures subjected to different 
pressure levels. RT–PCR assays 
were performed to detect changes 
in mRNA expression levels in 
primate retinal organotypic cultures 
subjected to different levels of pres-
sure for 24 h (A) and 72 h (B). Fold 
changes are expressed in compar-
ison to the average mRNA levels in 
cultures exposed to ambient atmo-
spheric pressure (0 mmHg; thus the 
0 mmHg group would have a mean 
of 1). Error bars represent standard 
error of the mean.
Figure 5. Complement component 
1, q subcomponent (C1q) and 
complement factor H (CFH) protein 
levels in mouse and primate retinal 
organotypic cultures subjected to 
different pressure levels. Shown 
are quantifications of immunoblot-
ting analysis of protein levels of 
C1q in primate organotypic retinal 
cultures subjected to different 
levels of pressure for either 24 (A) 
or 72 (B) hours. Quantification of immunoblotting analysis of CFH protein levels in primate retinal organotypic cultures subjected to 
different pressure levels for 72 h are presented in (C). Protein levels are normalized to the average level of the respective protein from cultures 
exposed to ambient atmospheric pressure (0 mmHg; thus the 0 mmHg group would have a mean of 1). Error bars represent standard error 
of the mean. (ANOVA; p>0.05).
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DISCUSSION
Circulating complement has traditionally been thought of as 
an arm of the innate immune system, charged with opso-
nizing and, in some instances, lysing invading pathogens. 
More recently, it has emerged that complement has often 
immunomodulatory functions. It is therefore not surprising 
that complement appears to be involved in several systemic 
autoimmune conditions [26,27].
Up until the early 1990s, it was not well appreciated 
that CNS not only has the capability but actually produces 
most, if not all, complement components. Since that time, 
complement has been implicated in several neurodegenera-
tive conditions [28,29]. At the same time, recent results have 
suggested that certain complement proteins may facilitate 
neuroprotection [30]. Similarly to the CNS, complement is 
also locally produced in the eye [5,31]. It has been postulated 
that locally produced complement plays a protective role in 
this immune-privileged organ [32]. However, in the past few 
years, several reports have linked complement with several 
degenerative eye conditions—most notably age-related 
macular degeneration [33] and glaucoma [4,5,34].
The involvement of complement in glaucomatous RGC 
loss and axonal degeneration is intriguing. Complement 
upregulation in the DBA/2J model of glaucoma occurs early, 
before the pathology becomes apparent, and continues even 
after significant RGC loss has occurred [4]. Similar observa-
tions were made in a rat glaucomatous model and in human 
glaucoma specimens [5]. Proteomic analysis in human tissue 
showed upregulation of both C1q and C3 but also the down-
regulation of CFH in human glaucomatous retina [3].
It has been suggested that complement might have 
different roles in glaucomatous pathology based on the stage 
of the disease [17]. Early in the disease, deposition of the 
complement could be mediating removal of RGC dendritic 
synapses [11], thus lowering RGC electrical activation and 
promoting their survival. As cell death becomes inevitable 
and some of the RGCs start undergoing apoptosis, comple-
ment might be promoting clearance of the cell debris and by 
doing so attenuate the inflammatory responses [17]. On the 
other hand, it was suggested that complement deposited on 
RGCs may not only target the compromised cells but also 
cause a bystander lysis of healthy RGCs and exacerbate the 
pathology [5]. Additionally, deposition of the complement 
may in fact activate adjacent glial cells and cause them to 
become reactive and start synthesizing various inflamma-
tory mediators, including cytokines and superoxide radicals. 
Figure 6. Microbead-injected eyes develop higher intraocular pres-
sure (IOP). Eyes exposed to microbead injections in the anterior 
chamber developed significantly higher cumulative IOP (ANOVA; 
p<0.0065) compared to the contralateral eyes and eyes of the naive 
animals. Error bars represent standard error of the mean, *p<0.05.
Figure 7. Effect of short-term 
microbead-induced intraocular 
pressure elevation on the comple-
ment system in the retina of 
C57BL/6 mice. Short-term (7 days) 
microbead-induced intraocular 
pressure (IOP) elevation did not 
produce changes in either comple-
ment component mRNA levels 
(A; t test; p>0.05) or complement 
component 1, q subcomponent 
(C1q) protein (B) expression levels 
(ANOVA; p>0.05) in the retinas 
of C57BL/6 mice. mRNA and C1q 
protein levels are normalized to the average level of the respective gene and C1q protein from retinas of naïve control mice (thus the naïve 
control group would have a mean of 1). Error bars represent standard error of the mean.
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Synthesis of these molecules by adjacent astroglial and 
microglial cells could further damage RGCs. In fact, glial 
cell activation has been recently demonstrated to be one of 
the pathological mechanisms that operate in glaucomatous 
disease [35,36].
It is clear that the role of the complement system in glau-
coma is a complex one. It thus requires careful dissection of 
potential factors and mechanisms that could be responsible 
for its activation. Given the impact of IOP on glaucoma patho-
genesis, we attempted to examine whether pressure elevation 
can affect the complement system.
Cell lines are a powerful tool for dissecting responses 
of individual components of a complex tissue to different 
experimental conditions. In recent years several retinal cell 
lines have been established, including a rat Muller cell line 
(TR-MUL5) [18,37] and a human Muller cell line (MIO-M1) 
[38], among others. Those lines have been extensively used 
to understand behavior of particular retinal cell types under 
various conditions. For example, Muller cell lines were used 
in studies that looked at the effects of excess extracellular 
glutamate [39] as well as of osmotic stress [40].
Recent studies have suggested that Muller cells are 
capable of producing complement system components and 
may regulate complement activation within the retina [41]. 
In addition, our earlier work [4] has suggested that Muller 
cells and astrocytes are responsible for complement produc-
tion in the retina in glaucoma. In this study, we examined 
the effect of pressure elevation on Muller cells by using a 
TR-MUL5 cell culture. Similar models have been used in the 
past to identify molecular changes that occur in response to 
high pressure. For example, they have been used to show that 
elastin synthesis by glial cells is affected by high pressure 
[42] and that elevated pressure induces apoptosis [43] and 
oxidative stress in cultured RGCs [44].
We did not detect any significant changes in the levels 
of complement components, at least within the timeframe of 
this experiment and for the pressure levels studied. These 
pressure levels were selected to represent normal (15 mmHg), 
moderately high (30 mmHg), and very high (45 mmHg) pres-
sure levels that can be encountered by retinal cells in vivo. 
Other studies that used such an ex vivo system have often 
looked at pressure levels that are outside the physiologic range 
[43-47]. Although the lack of effect of elevated pressure on 
complement expression by Muller cells can be interpreted as 
an inherent lack of responsiveness, other potential explana-
tions could be that additional cells or factors are required, 
as has been reported for other cell types in the retina [48], 
or that immortalized cell lines have lost such a capacity. Yet 
another possible explanation is that a longer exposure to the 
elevated pressure is needed to induce detectable upregulation 
of complement components. Of course we cannot completely 
rule out small changes in complement system expression that 
were below the detection limit of our methodology.
In contrast to cell lines, organotypic cultures allow 
evaluation of responses of the entire tissue to different 
conditions under investigation. At the same time, they retain 
much of the flexibility and scalability of an in vitro system. 
Retinal organotypic cultures have been used to assess the 
regeneration potential of RGCs [49], the effects of stem cell 
transplantation [50], glutamate excitotoxicity [51], as well as 
the effects of drug treatment [52]. Recently, it has also been 
shown that organotypic retinal cultures can be used for gene 
transfer studies [53].
In this study we employed retinal organotypic cultures 
from mice and monkeys to assess the effects of pressure 
elevation. Experiments with murine explants allowed direct 
comparison of the results from some of the cell culture 
experiments with the rodent cell lines as well as with in vivo 
experiments in mice (see below). On the other hand, using 
primate tissue allowed us to address potential interspecies 
variability. It also allows us to relate the findings to human 
disease.
It has been shown that rodent organotypic retinal cultures 
can be maintained in culture up to 17 days without significant 
alterations in laminar architecture of the retina [20]. Other 
groups have observed that organotypic tissue cultures could 
be kept morphologically and structurally intact for at least 4 
days [53]. In the current study we used a protocol that allows 
long survival of the tissue in culture [20]. We used the same 
protocol and media for the monkey retinal explants. Under 
the same conditions, organotypic cultures from donor post-
mortem human eyes have been maintained for up to 96 h with 
preservation of human retinal architecture and no notable 
decrease in thickness/density of the nuclear layers [54]. Inline 
with the above reports, we did not observe any morphological 
alterations in the retinal tissue for culture periods up to 72 h.
Neither murine nor primate explants exhibited changes 
in the expression of complement genes after exposure to 
elevated pressure for either 24 or 72 h. Similarly, the levels 
of C1q and CFH proteins remained unchanged over the range 
of pressures, further supporting the conclusion that short-
term elevation of pressure does not affect locally synthesized 
complement in the retina.
It has been suggested that elevation of pressure does 
not cause stress to the cells resting on a rigid support to any 
appreciable degree; even pressure elevations of 50 mmHg 
are calculated to cause relative deformations of cellular 
Molecular Vision 2014; 20:140-152 <http://www.molvis.org/molvis/v20/140> © 2014 Molecular Vision 
148
components of less than 0.005% [55]. Nonetheless, several 
studies employing different cell lines resting on a rigid 
support that were subjected to different levels of pressure 
have documented various biologic responses to pressure 
elevation [43,56].
The discrepancy between the lack of substantial cell 
deformation and observed major biologic responses to pres-
sure elevation has been puzzling. It has been recently argued 
[57] that most of the studies in which biologic response to 
pressure were observed have actually been documenting 
responses to differences in oxygen (and other gasses) tension 
that were not accounted for in the designs of those experi-
ments. Use of a vertical column of medium to exert elevated 
pressure hydrostatically on the cells located at the bottom 
of the column causes the cells at the bottom to experience 
decreased oxygen (and increased CO2) tensions because of 
differences in diffusion of gases through variable amounts 
of fluid. If oxygen tension were controlled, astrocytes under 
different levels of pressure did not show significant differ-
ences in migration [57]. Another potential confounding factor 
is bottle-to-bottle differences in gas tension of the medium, 
which might also contribute to different oxygen (or CO2) 
tensions that the cells experience in the incubator atmosphere 
[57].
On the other hand, a recent study that looked at mecha-
nosensitive channel TRPV1 in cultured RGC-5 cells using 
methodology that eliminates diffusion issues has offered a 
potential explanation of how pressure alone could trigger 
various biologic responses [58]. It was shown that activa-
tion of TRPV1 contributes to the apoptotic cell death of 
ganglion cells induced by pressure elevation [58]. The authors 
discussed several ways that elevated pressure could bring 
about activation of these channels and induce the downstream 
apoptotic pathways. In particular, cell membrane compres-
sion due to elevated pressure could disrupt the cytoskeletal 
scaffolding, and this, in turn, could affect the conductance of 
channels sensitive to mechanical tension.
The design of our experiment as well as utilization of an 
active pressurization and feedback system similar to the one 
used in this study [58] addresses some of the issues mentioned 
above when using columns of fluid to affect pressure hydro-
statically. First, cell cultures and organotypic retinal cultures 
are maintained under ambient pressure in the incubator 
overnight before they are subjected to elevated pressure the 
following day. This allows equilibration with the incubator 
gases and minimizes potential variability of gas tensions in 
different bottles of medium. Second, an active pressurization 
system eliminates differences that could arise due to oxygen 
diffusion through the column of medium because under all 
conditions the column of the medium is the same (and is also 
negligible, only around 1–2 mm tall), whereas pressure eleva-
tion is achieved by a compressed gaseous mixture above the 
medium in the enclosed chamber.
According to Henry’s law, the amount of gas dissolved 
in a liquid is directly proportional to the partial pressure of 
that gas in equilibrium with the liquid. As such, an increase 
in pressure of oxygen in the enclosed chamber in our system 
will lead to an increase of the partial pressure of oxygen in 
the culture medium. However, those effects are small as the 
difference between chambers represents only an approxi-
mately 5% variation from atmospheric pressure (atmospheric 
pressure can range up to 15% at sea level). Thus, it is most 
likely that the difference in gene and/or protein expression 
between cultures exposed to different pressure levels is the 
direct result of pressure itself.
Similarly, the issue of how IOP causes damage to the 
retina and optic nerve has not been resolved. IOP is the pres-
sure inside the eye. As such, it applies a force that acts vertical 
to the retina and a tangential strain. As the retina is not a rigid 
structure, the pressure drop across the retina is minimal (as 
experiments involving simultaneous cannulation of the poste-
rior choroid and vitreous have shown [59]). Although there is 
undoubtedly some strain applied to the retina with changing 
IOP, scleral expansion (which would allow for force transfer 
to the retina by making the surface that the retina occupies 
larger) is minimal (less that 5 µm or about 0.007% of the eye 
circumference). Thus, if there is an effect of IOP on the retina 
itself (rather than the optic nerve), this effect is likely directly 
related to the actual pressure that the retina is subjected to.
As such, it is interesting that primate organotypic retinal 
cultures showed a pressure-related change in expression of 
GFAP. GFAP is upregulated early in response to injury within 
the CNS [60] and retina [61,62] and can be thought of as a 
marker of tissue “stress.” Despite the fact that GFAP expres-
sion is affected by pressure, none of the complement genes 
studied showed any change in expression in either cultured 
cells or retinas. At the same time, one has to keep in mind 
that in the organotypic culture model there is inherent and 
unavoidable tissue damage, which may precipitate general-
ized complement activation that may mask small changes 
caused by the pressure level difference. Inspection of the 
RT-qPCR dissociation curves from organotypic cultures and 
retinas from the in vivo experiments suggests that this is not 
the case, but such a possibility cannot be completely excluded.
Despite the appeal of in vitro experiments, it is in vivo 
studies that ultimately allow us to answer whether results 
from in vitro experiments are relevant to actual biologic 
processes occurring in the organism. Inducible models of 
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glaucoma in rodents have advantages of precise control of 
pathology onset. The recently developed microbead occlu-
sion model has been shown to induce RGC damage in mice 
mediated by increased IOP [63]. In this model appreciable 
RGC loss could be detected as early as 2 weeks after the 
onset of IOP elevation [21]. The experiments described 
above examined whether short-term elevation of IOP caused 
by microbead injection in the anterior chamber of the eye 
leads to upregulation of the complement system in the mouse 
retina. The results suggest that IOP elevation for up to 7 days 
in C57BL/6 mice does not produce changes in complement 
expression for any of the genes studied and in C1q protein 
levels. This finding is surprising given the potential role of 
complement in the pathogenesis of glaucoma. It is, however, 
possible that IOP elevation in these mice was not of sufficient 
duration to cause complement upregulation. We are pres-
ently studying complement expression in animals exposed to 
elevated IOP for longer periods of time.
In the present study, we attempted to investigate the 
effect of short-term pressure elevation on complement gene 
expression in the retina by using a multifaceted approach 
that combined various in vitro and in vivo models. Studies 
in TR-MUL5 cell lines did not detect significant changes 
in cell responses to elevated pressure for up to 3 days in 
culture. Using an in vitro system in which entire retinal tissue 
is subjected to elevated pressure, i.e., organotypic retinal 
cultures, we similarly did not detect any significant changes 
in complement upregulation as a function of elevated pressure 
for up to 3 days. Those results were mirrored by the data 
from an in vivo model in which we subjected mouse retinas to 
experimental IOP elevation for 7 days. Combined, our results 
show that short-term exposure to elevated pressure alone 
does not dramatically affect complement gene expression in 
rodents and in organotypic cultures in primates.
This study was designed to test the null hypothesis that 
pressure does not affect complement expression in the retina. 
As such, the results of this study cannot be used as proof that 
such changes do not occur. To do that, a study with much 
higher power testing and an alternative null hypothesis would 
be technically needed. However, the absence of changes in 
complement activation across all the models employed in the 
current study strongly suggests that reported involvement of 
the complement system in glaucoma is independent of short-
term changes of IOP. Either long-term elevation in IOP leads 
to pronounced cumulative effects of pressure or an additional 
stimulus is required to cause complement upregulation and 
activation, like the one seen in DBA/2J mice [4], laser-treated 
rats [5], or patients having glaucoma [3-5]. Additional studies 
are needed to elucidate the role of complement activation in 
glaucoma.
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